Cargando…

Effective treatment of severe COVID-19 patients with tocilizumab

After analyzing the immune characteristics of patients with severe coronavirus disease 2019 (COVID-19), we have identified that pathogenic T cells and inflammatory monocytes with large amount of interleukin 6 secreting may incite the inflammatory storm, which may potentially be curbed through monocl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Xiaoling, Han, Mingfeng, Li, Tiantian, Sun, Wei, Wang, Dongsheng, Fu, Binqing, Zhou, Yonggang, Zheng, Xiaohu, Yang, Yun, Li, Xiuyong, Zhang, Xiaohua, Pan, Aijun, Wei, Haiming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	National Academy of Sciences 2020
Materias:	Biological Sciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245089/ https://www.ncbi.nlm.nih.gov/pubmed/32350134 http://dx.doi.org/10.1073/pnas.2005615117

Ejemplares similares

Why tocilizumab could be an effective treatment for severe COVID-19?
por: Fu, Binqing, et al.
Publicado: (2020)

Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trial
por: Wang, Dongsheng, et al.
Publicado: (2021)

Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients
por: Zhou, Yonggang, et al.
Publicado: (2020)

Tocilizumab is recommended for the treatment of severe COVID-19
por: Zhou, Yonggang, et al.
Publicado: (2020)

Inflammatory monocytes promote pre-engraftment syndrome and tocilizumab can therapeutically limit pathology in patients
por: Jin, Linlin, et al.
Publicado: (2021)

Profiling of the immune repertoire in COVID-19 patients with mild, severe, convalescent, or retesting-positive status
por: Zhou, Yonggang, et al.
Publicado: (2021)

Human-Induced CD49a(+) NK Cells Promote Fetal Growth
por: Du, Xianghui, et al.
Publicado: (2022)

Single-cell analysis of two severe COVID-19 patients reveals a monocyte-associated and tocilizumab-responding cytokine storm
por: Guo, Chuang, et al.
Publicado: (2020)

Interactions between driver genes shape the signaling pathway landscape and direct hepatocellular carcinoma therapy
por: Shen, Yiqing, et al.
Publicado: (2023)

Tumor-infiltrating platelets promote the growth of lung adenocarcinoma
por: Li, Xiaohui, et al.
Publicado: (2023)

Rapamycin Pretreatment Rescues the Bone Marrow AML Cell Elimination Capacity of CAR-T Cells
por: Nian, Zhigang, et al.
Publicado: (2021)

LCN2 secreted by tissue-infiltrating neutrophils induces the ferroptosis and wasting of adipose and muscle tissues in lung cancer cachexia
por: Wang, Dong, et al.
Publicado: (2023)

Hepatectomy promotes recurrence of liver cancer by enhancing IL-11-STAT3 signaling
por: Wang, Dongyao, et al.
Publicado: (2019)

Programmed differentiated natural killer cells kill leukemia cells by engaging SLAM family receptors
por: Wu, Yang, et al.
Publicado: (2017)

Advances in Immunotherapy for Hepatitis B
por: Wang, Dongyao, et al.
Publicado: (2022)

IL-6 modulation for COVID-19: the right patients at the right time?
por: Ascierto, Paolo Antonio, et al.
Publicado: (2021)

Functional mechanism of hsa-miR-128-3p in epithelial-mesenchymal transition of pancreatic cancer cells via ZEB1 regulation
por: Zheng, Tianying, et al.
Publicado: (2022)

Immunogenic senescence sensitizes lung cancer to LUNX-targeting therapy
por: Jiao, Defeng, et al.
Publicado: (2021)

Cytomegalovirus-specific neutralizing antibodies effectively prevent uncontrolled infection after allogeneic hematopoietic stem cell transplantation
por: Wang, Huiru, et al.
Publicado: (2022)

Immunomagnetic microscopy of tumor tissues using quantum sensors in diamond
por: Chen, Sanyou, et al.
Publicado: (2022)

Transcriptomic characteristics and impaired immune function of patients who retest positive for SARS-CoV-2 RNA
por: Wang, Dongyao, et al.
Publicado: (2021)

GARP-mediated active TGF-β1 induces bone marrow NK cell dysfunction in AML patients with early relapse post–allo-HSCT
por: Wang, Dongyao, et al.
Publicado: (2022)

Effectiveness of convalescent plasma therapy in severe COVID-19 patients
por: Duan, Kai, et al.
Publicado: (2020)

GPCR large-amplitude dynamics by (19)F-NMR of aprepitant bound to the neurokinin 1 receptor
por: Pan, Benxun, et al.
Publicado: (2022)

Tocilizumab in severe COVID-19
por: Lucio Liberato, Nicola, et al.
Publicado: (2020)

Spectrin regulates Hippo signaling by modulating cortical actomyosin activity
por: Deng, Hua, et al.
Publicado: (2015)

Influenza Vaccine Induces Intracellular Immune Memory of Human NK Cells
por: Dou, Yaling, et al.
Publicado: (2015)

Cytokine-Based Generation of CD49a(+)Eomes(−/+) Natural Killer Cell Subsets
por: Ni, Xiang, et al.
Publicado: (2018)

Downregulation of apoptotic repressor AVEN exacerbates cardiac injury after myocardial infarction
por: Yu, Peng, et al.
Publicado: (2023)

GmEID1 modulates light signaling through the Evening Complex to control flowering time and yield in soybean
por: Qin, Chao, et al.
Publicado: (2023)

Efficacy of tocilizumab treatment in severely ill COVID-19 patients
por: Zhao, Jie, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia
por: Mourad, Jean-Jacques, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia
por: Lipworth, Brian J, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia
por: Piano, Salvatore, et al.
Publicado: (2020)

Efficacy of the early treatment with tocilizumab-hydroxychloroquine and tocilizumab-remdesivir in severe COVID-19 Patients
por: Sarhan, Rania M., et al.
Publicado: (2022)

Tocilizumab, an Exploratory Treatment for Severe COVID-19 Patients
por: Wang, Yong, et al.
Publicado: (2022)

LunX-CAR T Cells as a Targeted Therapy for Non-Small Cell Lung Cancer
por: Hu, Ziming, et al.
Publicado: (2020)

Pyroptotic macrophages stimulate the SARS-CoV-2-associated cytokine storm
por: Zhang, Jinghe, et al.
Publicado: (2021)

TGF-β1 Down-Regulation of NKG2D/DAP10 and 2B4/SAP Expression on Human NK Cells Contributes to HBV Persistence
por: Sun, Cheng, et al.
Publicado: (2012)

CD11b(−)CD27(−) NK Cells Are Associated with the Progression of Lung Carcinoma
por: Jin, Jing, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_9k2h91t726dmjccd7n53q2enuu